The Humanistic and Economic Burden of Alzheimer's Disease

  title={The Humanistic and Economic Burden of Alzheimer's Disease},
  author={Amir Abbas Tahami Monfared and Michael J. Byrnes and Leigh Ann White and Quanwu Zhang},
  journal={Neurology and Therapy},
  pages={525 - 551}
Alzheimer’s disease (AD) is the leading cause of cognitive impairment and dementia in older individuals (aged ≥ 65 years) throughout the world. As a result of these progressive deficits in cognitive, emotional, and physical function, AD dementia can cause functional disability and loss of independence. To gain a deeper understanding of the recent literature on the burden of AD, including that of mild cognitive impairment (MCI) due to AD, we conducted a comprehensive targeted review of the… 
Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update
Evidence from human and animal studies show that BVR-A alterations are associated with the aberrant activation of insulin signaling, metabolic syndrome, liver steatosis, and visceral adipose tissue inflammation in obese and diabetic individuals.
Amyloid Beta Oligomers-Induced Ca2+ Entry Pathways: Role of Neuronal Networks, NMDA Receptors and Amyloid Channel Formation
It is concluded that Aβ oligomers promote Ca2+ entry via amyloid channels and NMDA receptors, leading to excitotoxicity and neuron degeneration in AD.


Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study.
The results confirmed that awareness and cognition are relatively independent, and showed that in people with mild dementia, unawareness is mainly manifested by poor recognition of changes in the activities of daily living, and decrease in quality of life.
Impact of functional alterations on quality of life in patients with Alzheimer's disease
Alterations in functional capacity have a significant effect on HRQoL in several domains of the DQaL in patients with Alzheimer's disease, focusing particularly on functional alterations.
Awareness of Mild Cognitive Impairment and Mild Alzheimer’s Disease Dementia Diagnoses Associated With Lower Self-Ratings of Quality of Life in Older Adults
People aware of their diagnostic label-either MCI or AD-and its prognosis report lower QOL than those unaware of these facts about themselves, independent of the severity of cognitive impairment.
Quality of Life in Alzheimer Disease: A Comparison of Patients’ and Caregivers’ Points of View
The findings suggest that the use of proxies as a substitute for the self-report of QoL data should be treated with caution, always accounting for the presence of potential bias.
Observation of Patient and Caregiver Burden Associated with Early Alzheimer’s Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1
Considerable patient and caregiver burden was observed in patients seeking care for memory concerns and different patterns emerged when both disease severity and amyloid status were evaluated underscoring the need for further diagnostic assessment and care for patients.
Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes
Cognitive and, more notably, functional decline were associated with increases in costs and caregiver outcomes in patients with mild AD dementia.
Caregivers’ Perspectives of Quality of Life of People With Young- and Late-Onset Alzheimer Disease
The study provides basic information on caregivers’ perspectives of PwAD QoL to create more effective interventions according to the age at onset and indicates that caregivers’ burden, years of education, and self-reportedQoL were significantly related to the caregivers” perspective of LOAD QeL.
The impact of depressive symptoms on health-related quality of life in patients with subjective cognitive decline, mild cognitive impairment, and Alzheimer's disease
HRQOL and depressive symptoms are closely related in patients with cognitive impairments, therefore, it is of great importance to assess patients with subjective impairment carefully in terms of depressive symptoms.
Quality of life and factors affecting it in patients with Alzheimer’s disease: a cross-sectional study
It is suggested that both self- and proxy-rated QoL scores should be applied whenever possible to improve the quality of life of people with Alzheimer’s disease and that focusing on the management of behavioral problems and supporting functionality and cognitive functions may be modifiable factors that may represent targets for intervention.
Factors associated with long-term impact on informal caregivers during Alzheimer’s disease dementia progression: 36-month results from GERAS
Long-term informal caregiver burden was driven by worsening functional abilities and behavioral symptoms but not cognitive decline, over 18 months in community-dwelling patients with AD dementia.